4/11
04:01 pm
argx
argenx Announces Annual General Meeting of Shareholders on May 27, 2025
Medium
Report
argenx Announces Annual General Meeting of Shareholders on May 27, 2025
4/11
10:13 am
argx
argenx SE (NASDAQ: ARGX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $715.00 price target on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $715.00 price target on the stock.
4/10
05:47 pm
argx
argenx Announces FDA Approval of VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy
Medium
Report
argenx Announces FDA Approval of VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy
4/9
08:10 am
argx
argenx SE (NASDAQ: ARGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $720.00 price target on the stock.
Medium
Report
argenx SE (NASDAQ: ARGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $720.00 price target on the stock.
4/8
01:00 am
argx
argenx Highlights VYVGART Data at AAN 2025 Setting New Standard in Sustained Efficacy and Improved Quality of Life Measures for Patients Living with gMG and CIDP
Low
Report
argenx Highlights VYVGART Data at AAN 2025 Setting New Standard in Sustained Efficacy and Improved Quality of Life Measures for Patients Living with gMG and CIDP
3/17
08:02 am
argx
argenx SE (NASDAQ: ARGX) was upgraded by analysts at Sanford C. Bernstein from a "market perform" rating to an "outperform" rating.
Low
Report
argenx SE (NASDAQ: ARGX) was upgraded by analysts at Sanford C. Bernstein from a "market perform" rating to an "outperform" rating.
3/12
07:22 am
argx
argenx SE (NASDAQ: ARGX) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "sell" rating to a "hold" rating.
Low
Report
argenx SE (NASDAQ: ARGX) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "sell" rating to a "hold" rating.
3/10
11:11 am
argx
argenx SE (NASDAQ: ARGX) had its "outperform" rating re-affirmed by analysts at Citigroup Inc..
Low
Report
argenx SE (NASDAQ: ARGX) had its "outperform" rating re-affirmed by analysts at Citigroup Inc..
3/10
11:11 am
argx
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Guggenheim from $775.00 to $1,100.00. They now have a "buy" rating on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Guggenheim from $775.00 to $1,100.00. They now have a "buy" rating on the stock.
3/7
01:00 am
argx
argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at the American Academy of Neurology 2025 Annual Meeting
Medium
Report
argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at the American Academy of Neurology 2025 Annual Meeting
3/4
09:54 am
argx
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Robert W. Baird from $650.00 to $680.00. They now have a "neutral" rating on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Robert W. Baird from $650.00 to $680.00. They now have a "neutral" rating on the stock.
2/28
12:49 pm
argx
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Oppenheimer Holdings Inc. from $675.00 to $704.00. They now have an "outperform" rating on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Oppenheimer Holdings Inc. from $675.00 to $704.00. They now have an "outperform" rating on the stock.
2/28
12:49 pm
argx
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Wells Fargo & Company from $723.00 to $741.00. They now have an "overweight" rating on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Wells Fargo & Company from $723.00 to $741.00. They now have an "overweight" rating on the stock.
2/28
12:30 pm
argx
argenx SE (NASDAQ: ARGX) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
argenx SE (NASDAQ: ARGX) had its "outperform" rating re-affirmed by analysts at William Blair.
2/28
08:13 am
argx
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at HC Wainwright from $717.00 to $720.00. They now have a "buy" rating on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at HC Wainwright from $717.00 to $720.00. They now have a "buy" rating on the stock.
2/27
01:00 am
argx
argenx Reports Full Year 2024 Financial Results and Provides Fourth Quarter Business Update
Low
Report
argenx Reports Full Year 2024 Financial Results and Provides Fourth Quarter Business Update
2/25
01:00 am
argx
argenx to Present at TD Cowen 45th Annual Healthcare Conference
Low
Report
argenx to Present at TD Cowen 45th Annual Healthcare Conference
2/20
01:00 am
argx
argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025
Low
Report
argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025
1/17
02:26 pm
argx
argenx SE (NASDAQ: ARGX) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "sell" rating.
Low
Report
argenx SE (NASDAQ: ARGX) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "sell" rating.
1/14
12:43 pm
argx
argenx SE (NASDAQ: ARGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $717.00 price target on the stock, up previously from $670.00.
Low
Report
argenx SE (NASDAQ: ARGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $717.00 price target on the stock, up previously from $670.00.
1/14
10:57 am
argx
argenx SE (NASDAQ: ARGX) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $700.00 price target on the stock, up previously from $660.00.
Low
Report
argenx SE (NASDAQ: ARGX) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $700.00 price target on the stock, up previously from $660.00.
1/14
08:56 am
argx
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at JMP Securities from $606.00 to $696.00. They now have a "market outperform" rating on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at JMP Securities from $606.00 to $696.00. They now have a "market outperform" rating on the stock.